134 related articles for article (PubMed ID: 8999809)
1. Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse.
Chen S; Knox R; Wu K; Deng PS; Zhou D; Bianchet MA; Amzel LM
J Biol Chem; 1997 Jan; 272(3):1437-9. PubMed ID: 8999809
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
Wu K; Eng E; Knox R; Chen S
Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
4. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling.
Chen S; Wu K; Zhang D; Sherman M; Knox R; Yang CS
Mol Pharmacol; 1999 Aug; 56(2):272-8. PubMed ID: 10419545
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
[TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).
Chen S; Wu K; Knox R
Free Radic Biol Med; 2000 Aug; 29(3-4):276-84. PubMed ID: 11035256
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human DT-diaphorase: a model for interaction with the cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954).
Skelly JV; Sanderson MR; Suter DA; Baumann U; Read MA; Gregory DS; Bennett M; Hobbs SM; Neidle S
J Med Chem; 1999 Oct; 42(21):4325-30. PubMed ID: 10543876
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of rat liver NAD(P)H: quinone oxidoreductase: roles of lysine 76 and cysteine 179.
Ma Q; Cui K; Wang RW; Lu AY; Yang CS
Arch Biochem Biophys; 1992 May; 294(2):434-9. PubMed ID: 1567199
[TBL] [Abstract][Full Text] [Related]
10. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
11. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
Boland MP; Knox RJ; Roberts JJ
Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):867-75. PubMed ID: 1901207
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
[TBL] [Abstract][Full Text] [Related]
13. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
Horie S
Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
[TBL] [Abstract][Full Text] [Related]
14. Expression of rat liver NAD(P)H:quinone-acceptor oxidoreductase in Escherichia coli and mutagenesis in vitro at Arg-177.
Chen HH; Ma JX; Forrest GL; Deng PS; Martino PA; Lee TD; Chen S
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):855-60. PubMed ID: 1622401
[TBL] [Abstract][Full Text] [Related]
15. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
[TBL] [Abstract][Full Text] [Related]
16. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.
Knox RJ; Friedlos F; Sherwood RF; Melton RG; Anlezark GM
Biochem Pharmacol; 1992 Dec; 44(12):2297-301. PubMed ID: 1472095
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
[TBL] [Abstract][Full Text] [Related]
18. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
Yoshida T; Tsuda H
Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
[TBL] [Abstract][Full Text] [Related]
19. Nitrobenzimidazoles as substrates for DT-diaphorase and redox cycling compounds: their enzymatic reactions and cytotoxicity.
Sarlauskas J; Dickancaite E; Nemeikaite A; Anusevicius Z; Nivinskas H; Segura-Aguilar J; Cenas N
Arch Biochem Biophys; 1997 Oct; 346(2):219-29. PubMed ID: 9343369
[TBL] [Abstract][Full Text] [Related]
20. Phthalimide analogs of CB 1954: synthesis and bioactivation.
Mehta LK; Hobbs S; Chen S; Knox RJ; Parrick J
Anticancer Drugs; 1999 Sep; 10(8):777-83. PubMed ID: 10573210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
